Discover
AGIO
Agios Pharmaceuticals, Inc.
33.49
4 x 33.47
1 x 33.53
bid
ask
+
0.90
2.78%
12:31 PM
timesize
| Ytd | 23.05% | |
| 1y | -4.52% |
32.23
day range
33.60
22.24
52 week range
46.00
| Open | 33.05 | Prev Close | 32.59 | Low | 32.23 | High | 33.60 | Mkt Cap | 2.00B |
| Vol | 276.38K | Avg Vol | 1.12M | EPS | -7.25 | P/E | -4.62 | Forward P/E | -7.69 |
| Beta | 0.58 | Short Ratio | 5.44 | Inst. Own | 110.17% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-30 | 50-d Avg | 34.55 | 200-d Avg | 31.32 | 1yr Est | 45.75 |
| Income Statement | |||
| Total Revenue | 44.75M | ||
| Revenues (USD) | 44.75M | ||
| Cost of Revenue | 3.00M | ||
| Gross Profit | 41.75M | ||
| Operating Expenses | 152.30M | ||
| Research and Development Expense | 100.75M | ||
| Selling, General and Administrative Expense | 51.55M | ||
| Operating Income | -110.55M | ||
| Net Income | -100.70M | ||
| Net Income Common Stock | -100.70M | ||
| Net Income Common Stock (USD) | -100.70M | ||
| Consolidated Income | -100.70M | ||
| Earnings per Basic Share | -1.69 | ||
| Earnings per Basic Share (USD) | -1.69 | ||
| Earnings per Diluted Share | -1.69 | ||
| Earning Before Interest & Taxes (EBIT) | -100.70M | ||
| Earning Before Interest & Taxes (USD) | -100.70M | ||
| Weighted Average Shares | 59.49M | ||
| Weighted Average Shares Diluted | 59.49M | ||
| Balance Sheet | |||
| Cash and Equivalents | 99.65M | ||
| Cash and Equivalents (USD) | 99.65M | ||
| Investments | 865.18M | ||
| Investments Current | 517.93M | ||
| Investments Non-Current | 347.25M | ||
| Trade and Non-Trade Receivables | 20.11M | ||
| Current Assets | 717.67M | ||
| Property, Plant & Equipment Net | 33.82M | ||
| Total Assets | 1.11B | ||
| Debt Current | 19.23M | ||
| Total Debt | 31.17M | ||
| Current Liabilities | 70.22M | ||
| Debt Non-Current | 11.95M | ||
| Total Liabilities | 82.40M | ||
| Accumulated Retained Earnings (Deficit) | -761.52M | ||
| Accumulated Other Comprehensive Income | -1.79M | ||
| Shareholders Equity | 1.03B | ||
| Shareholders Equity (USD) | 1.03B | ||
| Assets Non-Current | 390.76M | ||
| Total Debt (USD) | 31.17M | ||
| Inventory | 30.15M | ||
| Liabilities Non-Current | 12.19M | ||
| Trade and Non-Trade Payables | 16.35M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 4.67M | ||
| Net Cash Flow from Financing | 3.15M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -13.95M | ||
| Capital Expenditure | -1.21M | ||
| Issuance (Purchase) of Equity Shares | 3.15M | ||
| Net Cash Flow from Investing | 40.21M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 66.42M | ||
| Net Cash Flow from Operations | -57.31M | ||
| Share Based Compensation | 15.94M | ||